Pharmacological Agents for Developmental Stuttering in Children and Adolescents
| Autor: | Katharina Dworzynski, Alexander B. Boyd, Peter Howell |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Olanzapine
medicine.medical_specialty Stuttering Adolescent MEDLINE Tiapride chemistry.chemical_compound Pharmacotherapy Intervention (counseling) medicine Humans Pharmacology (medical) Child Psychiatry Risperidone business.industry Clonidine Psychiatry and Mental health Treatment Outcome chemistry medicine.symptom business Antipsychotic Agents medicine.drug Clinical psychology |
| Zdroj: | Journal of Clinical Psychopharmacology. 31:740-744 |
| ISSN: | 0271-0749 |
| Popis: | Stuttering affects approximately 5% of children up to the teenage years. There are many possible forms of intervention, one of which is pharmacotherapy. No review about the treatment of stuttering with pharmacological agents in children and adolescents has been undertaken. The objectives of this review were to determine the extent of previous research in this area and to assess the success of pharmacological agents in reducing the frequency of disfluency in child and adolescent stutterers ( |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|